1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        SAM Enzyme Replacement Therapy Market – By Enzyme Type

1.3.2        SAM Enzyme Replacement Therapy Market – By Therapeutic Conditions

1.3.3        SAM Enzyme Replacement Therapy Market – By Route of Administration

1.3.4        SAM Enzyme Replacement Therapy Market – By End User

1.3.5        SAM Enzyme Replacement Therapy Market – By Country

2.           SAM Enzyme Replacement Therapy Market– Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           SAM Enzyme Replacement Therapy Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        South & Central America – PEST Analysis

4.3         Expert Opinion

5.           SAM Enzyme Replacement Therapy Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Prevalence of Lysosomal Storage Diseases (LSDs)

5.1.2        Rapid Regulatory Approval with Other Benefits for Drug with Orphan Drug Designation

5.2         Market Restraints

5.2.1        Cutthroat Competition among Market Players

5.3         Market Opportunities

5.3.1        Increasing Partnerships and Collaborations to Synergize the Business

5.4         Future Trends

5.4.1        Innovative Developments in ERT

5.5         Impact Analysis

6.           Enzyme Replacement Therapy Market– SAM Analysis

6.1         SAM Enzyme Replacement Therapy Market Revenue Forecast and Analysis

7.           SAM Enzyme Replacement Therapy Market Revenue and Forecasts To 2028– by Enzyme Type

7.1         Overview

7.2         SAM Enzyme Replacement Therapy Market, By Enzyme Type 2021 & 2028 (%)

7.3         Alglucosidase Alfa

7.3.1        Overview

7.3.2        Alglucosidase Alfa Revenue and Forecast to 2028 (US$ Million)

7.4         Agalsidase Beta

7.4.1        Overview

7.4.2        Agalsidase Beta - Revenue and Forecast to 2028 (US$ Million)

7.5         Imiglucerase

7.5.1        Overview

7.5.2        Imigluceras - Revenue and Forecast to 2028 (US$ Million)

7.6         Idursulfase

7.6.1        Overview

7.6.2        Idursulfase - Revenue and Forecast to 2028 (US$ Million)

7.7         Galsulfase

7.7.1        Overview

7.7.2        Galsulfase - Revenue and Forecast to 2028 (US$ Million)

7.8         Velaglucerase Alfa

7.8.1        Overview

7.8.2        Velaglucerase Alfa - Revenue and Forecast to 2028 (US$ Million)

7.9         Other Enzymes

7.9.1        Overview

7.9.2        Other Enzymes - Revenue and Forecast to 2028 (US$ Million)

8.           SAM Enzyme Replacement Therapy Market Analysis And Forecasts To 2028 – By Therapeutic Conditions

8.1         Overview

8.2         SAM Enzyme Replacement Therapy Market, By Therapeutic Conditions 2021 & 2028 (%)

8.3         Gaucher's Disease

8.3.1        Overview

8.3.2        Gaucher's Disease - Market Revenue and Forecast to 2028 (US$ Million)

8.4         Fabry's Disease

8.4.1        Overview

8.4.2        Fabry's Disease - Market Revenue and Forecast to 2028 (US$ Million)

8.5         Mucopolysaccharidosis (MPS)

8.5.1        Overview

8.5.2        MPS - Market Revenue and Forecast to 2028 (US$ Million)

8.6         Pompe's Disease

8.6.1        Overview

8.6.2        Pompe's Disease - Market Revenue and Forecast to 2028 (US$ Million)

8.7         SCID

8.7.1        Overview

8.7.2        SCID - Market Revenue and Forecast to 2028 (US$ Million)

8.8         Other Therapeutic Conditions

8.8.1        Overview

8.8.2        Other Therapeutic Conditions - Market Revenue and Forecast to 2028 (US$ Million)

9.           SAM Enzyme Replacement Therapy Market Analysis and Forecasts To 2028 – By Route of Administration

9.1         Overview

9.2         SAM Enzyme Replacement Therapy Market, By Route of Administration 2021 & 2028 (%)

9.3         Parenteral

9.3.1        Overview

9.3.2        Parenteral - Market Revenue and Forecast to 2028 (US$ Million)

9.4         Oral

9.4.1        Overview

9.4.2        Oral - Market Revenue and Forecast to 2028 (US$ Million)

10.        SAM Enzyme Replacement Therapy Market Analysis– By End User

10.1      Overview

10.2      SAM Enzyme Replacement Therapy Market, By End User 2021 & 2028 (%)

10.3      Hospitals

10.3.1     Overview

10.3.2     Hospitals - Market Revenue and Forecasts To 2028 (US$ Million)

10.4      Infusion Centers

10.4.1     Overview

10.4.2     Infusion Centers - Market Revenue and Forecasts To 2028 (US$ Million)

10.5      Others

10.5.1     Overview

10.5.2     Others - Market Revenue and Forecasts To 2028 (US$ Million)

11.        SAM Enzyme Replacement Therapy Market Revenue and Forecasts to 2028 – Country Analysis

11.1      South & Central America: Enzyme Replacement Therapy Market

11.1.1     Overview

11.1.2     South and Central America: Enzyme Replacement Therapy Market, by country, 2021 & 2028 (%)

11.1.2.1       Brazil: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.1       Brazil: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.1.2       Brazil: Enzyme Replacement Therapy Market, by Enzyme Type, 2019–2028 (USD Million)

11.1.2.1.3       Brazil: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019–2028 (USD Million)

11.1.2.1.4       Brazil: Enzyme Replacement Therapy Market, by Route of Administration, 2019–2028 (USD Million)

11.1.2.1.5       Brazil: Enzyme Replacement Therapy Market, by End User, 2019–2028 (USD Million)

11.1.2.2       Argentina: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.1       Argentina: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.2.2       Argentina: Enzyme Replacement Therapy Market, by Enzyme Type, 2019–2028 (USD Million)

11.1.2.2.3       Argentina: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019–2028 (USD Million)

11.1.2.2.4       Argentina: Enzyme Replacement Therapy Market, by Route of Administration, 2019–2028 (USD Million)

11.1.2.2.5       Argentina: Enzyme Replacement Therapy Market, by End User, 2019–2028 (USD Million)

11.1.2.3       Rest of South and Central America: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.1       Rest of South and Central America: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (USD Million)

11.1.2.3.2       Rest of South and Central America: Enzyme Replacement Therapy Market, by Enzyme Type, 2019–2028 (USD Million)

11.1.2.3.3       Rest of South and Central America: Enzyme Replacement Therapy Market, by Therapeutic Conditions, 2019–2028 (USD Million)

11.1.2.3.4       Rest of South and Central America: Enzyme Replacement Therapy Market, by Route of Administration, 2019–2028 (USD Million)

11.1.2.3.5       Rest of South and Central America: Enzyme Replacement Therapy Market, by End User, 2019–2028 (USD Million)

12.        SAM Enzyme Replacement Therapy Market–Industry Landscape

12.1      Overview

12.2      Inorganic Growth Strategies

12.2.1     Overview

12.3      Organic Growth Strategies

12.3.1     Overview

13.        Company Profiles

13.1      Sanofi

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      BioMarin Pharmaceutical Inc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Takeda Pharmaceutical Company Limited

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      AbbVie Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.)

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Alexion Pharmaceuticals, Inc. (AstraZeneca)

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     WOT Analysis

13.6.6     Key Developments

13.7      Amicus Therapeutics

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Recordati S.p.A.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      CHIESI Farmaceutici S.p.A.

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Pfizer Inc.

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             Brazil: Enzyme Replacement Therapy Market, by Enzyme Type – Revenue and Forecast to 2028 (USD Million)

Table 2.             Brazil: Enzyme Replacement Therapy Market, by Therapeutic Conditions – Revenue and Forecast to 2028 (USD Million)

Table 3.             Brazil: Enzyme Replacement Therapy Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 4.             Brazil: Enzyme Replacement Therapy Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 5.             Argentina: Enzyme Replacement Therapy Market, by Enzyme Type – Revenue and Forecast to 2028 (USD Million)

Table 6.             Argentina: Enzyme Replacement Therapy Market, by Therapeutic Conditions – Revenue and Forecast to 2028 (USD Million)

Table 7.             Argentina: Enzyme Replacement Therapy Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 8.             Argentina: Enzyme Replacement Therapy Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9.             Rest of South and Central America: Enzyme Replacement Therapy Market, by Enzyme Type – Revenue and Forecast to 2028 (USD Million)

Table 10.          Rest of South and Central America: Enzyme Replacement Therapy Market, by Therapeutic Conditions – Revenue and Forecast to 2028 (USD Million)

Table 11.          Rest of South and Central America: Enzyme Replacement Therapy Market, by Route of Administration– Revenue and Forecast to 2028 (USD Million)

Table 12.          Rest of South and Central America: Enzyme Replacement Therapy Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 13.          Recent Inorganic Growth Strategies in the Enzyme Replacement Therapy Market

Table 14.          Recent Organic Growth Strategies in the Enzyme Replacement Therapy Market

Table 15.          Glossary of Terms

LIST OF FIGURES

Figure 1.           SAM Enzyme Replacement Therapy Market Segmentation

Figure 2.           SAM Enzyme Replacement Therapy Market Segmentation, By Country

Figure 3.           SAM Enzyme Replacement Therapy Market Overview

Figure 4.           SAM Enzyme Replacement Therapy Market, By Enzyme Type

Figure 5.           SAM Enzyme Replacement Therapy Market, By Country

Figure 6.           South & Central America: PEST Analysis

Figure 7.           Expert Opinion

Figure 8.           SAM Impact Analysis

Figure 9.           SAM Enzyme Replacement Therapy Market– Revenue Forecast and Analysis – 2019- 2028

Figure 10.        SAM Enzyme Replacement Therapy Market, by Enzyme Type 2021 & 2028 (%)

Figure 11.        SAM Alglucosidase Alfa Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        SAM Agalsidase Beta - Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        SAM Imiglucerase - Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        SAM Idursulfase - Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        SAM Galsulfase - Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        SAM Velaglucerase Alfa - Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        SAM Other Enzymes - Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        SAM Enzyme Replacement Therapy Market, by Therapeutic Conditions 2021 & 2028 (%)

Figure 19.        SAM Gaucher's Disease - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20.        SAM Fabry's Disease - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        SAM MPS - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        SAM Pompe's Disease - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23.        SAM SCID - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24.        SAM Other Therapeutic Conditions - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25.        SAM Enzyme Replacement Therapy Market, by Route of Administration 2021 & 2028 (%)

Figure 26.        SAM Parenteral - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27.        SAM Oral - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28.        SAM Enzyme Replacement Therapy Market, by End User 2021 & 2028 (%)

Figure 29.        SAM Hospitals - Market Revenue and Forecasts To 2028 (US$ Million)

Figure 30.        SAM Infusion Centers - Market Revenue and Forecasts To 2028 (US$ Million)

Figure 31.        SAM Others- Market Revenue and Forecasts To 2028 (US$ Million)

Figure 32.        South and Central America: Enzyme Replacement Therapy Market, by Key Country – Revenue (2021) (US$' Million)

Figure 33.        South and Central America: Enzyme Replacement Therapy Market, by country, 2021 & 2028 (%)

Figure 34.        Brazil: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (USD Million)

Figure 35.        Argentina: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (USD Million)

Figure 36.        Rest of South and Central America: Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (USD Million)